0000899243-20-030032.txt : 20201030
0000899243-20-030032.hdr.sgml : 20201030
20201030201829
ACCESSION NUMBER: 0000899243-20-030032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201028
FILED AS OF DATE: 20201030
DATE AS OF CHANGE: 20201030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanchez Ramiro
CENTRAL INDEX KEY: 0001830326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 201278726
MAIL ADDRESS:
STREET 1: C/O CEREVELL THERAPEUTICS HOLDINGS INC.
STREET 2: 131 DARTMOUTH STREET SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-28
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001830326
Sanchez Ramiro
C/O CEREVEL THERAPEUTICS HOLDINGS, INC.
131 DARTMOUTH STREET, SUITE 502
BOSTON
MA
02116
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
9.88
2020-10-28
4
A
0
130890
0.00
A
2030-10-28
Common Stock
130890
130890
D
50% of this option shall vest and become exercisable on October 28, 2022, with the remainder vesting in two (2) equal annual installments thereafter.
/s/ Bryan K. Phillips, as Attorney-in-Fact
2020-10-30